Cogent Biosciences (COGT) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free COGT Stock Alerts $6.01 -0.53 (-8.10%) (As of 05:12 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cogent Biosciences Short Interest DataCurrent Short Volume12,470,000 sharesPrevious Short Volume10,840,000 sharesChange Vs. Previous Month+15.04%Dollar Volume Sold Short$81.06 millionShort Interest Ratio / Days to Cover5.9Last Record DateApril 15, 2024Outstanding Shares95,610,000 sharesPercentage of Shares Shorted13.04%Today's Trading Volume1,211,953 sharesAverage Trading Volume2,024,737 sharesToday's Volume Vs. Average60% Short Selling Cogent Biosciences ? Sign up to receive the latest short interest report for Cogent Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCOGT Short Interest Over TimeCOGT Days to Cover Over TimeCOGT Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Cogent Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202412,470,000 shares $81.06 million +15.0%N/A5.9 $6.50 3/31/202410,840,000 shares $72.84 million +12.6%N/A5 $6.72 3/15/20249,630,000 shares $67.89 million +6.2%N/A4.5 $7.05 2/29/20249,070,000 shares $63.49 million +45.4%N/A3.5 $7.00 2/15/20246,240,000 shares $55.41 million +23.8%N/A2.5 $8.88 1/31/20245,040,000 shares $22.33 million -5.6%N/A2.6 $4.43 Get the Latest News and Ratings for COGT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cogent Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/20245,340,000 shares $27.02 million -6.3%N/A3 $5.06 12/31/20235,700,000 shares $33.52 million -22.3%N/A3.5 $5.88 12/15/20237,340,000 shares $35.82 million -8.5%N/A4.8 $4.88 11/30/20238,020,000 shares $61.51 million +1.1%N/A6.3 $7.67 11/15/20237,930,000 shares $60.90 million +23.0%N/A9.4 $7.68 10/31/20236,450,000 shares $52.63 million +6.6%N/A8.3 $8.16 10/15/20236,050,000 shares $57.60 million +4.1%N/A8.3 $9.52 9/30/20235,810,000 shares $56.65 million -9.2%N/A8.5 $9.75 9/15/20236,400,000 shares $75.26 million -4.3%N/A9.5 $11.76 8/31/20236,690,000 shares $81.68 million +4.9%N/A9.8 $12.21 8/15/20236,380,000 shares $78.41 million +24.9%N/A8.7 $12.29 7/31/20235,110,000 shares $66.38 million +4.5%N/A6.9 $12.99 7/15/20234,890,000 shares $61.27 million -7.2%N/A7 $12.53 6/30/20235,270,000 shares $62.40 million -0.9%N/A7.2 $11.84 6/15/20235,320,000 shares $67.09 million +14.7%N/A7 $12.61 5/31/20234,640,000 shares $54.47 million +2.9%N/A6.5 $11.74 5/15/20234,510,000 shares $53.67 million -15.1%N/A7 $11.90 4/30/20235,310,000 shares $57.14 million -5.9%N/A8.5 $10.76 4/15/20235,640,000 shares $57.92 million -8.6%N/A9.5 $10.27 3/31/20236,170,000 shares $66.57 million -3.3%N/A10 $10.79 3/15/20236,380,000 shares $77.58 million +15.2%N/A9.9 $12.16 2/28/20235,540,000 shares $73.29 million +9.5%N/A7.8 $13.23 2/15/20235,060,000 shares $69.42 million +1.6%N/A6.8 $13.72 1/31/20234,980,000 shares $75.00 million -16.2%N/A6.5 $15.06 1/15/20235,940,000 shares $77.40 million +1.9%N/A7.5 $13.03 12/30/20225,830,000 shares $67.39 million +19.7%N/A7.8 $11.56 12/15/20224,870,000 shares $58.25 million -4.7%N/A6.4 $11.96 11/30/20225,110,000 shares $64.28 million +7.1%N/A6.4 $12.58 11/15/20224,770,000 shares $55.86 million +1.9%N/A5.7 $11.71 10/31/20224,680,000 shares $63.88 million -4.9%N/A4.7 $13.65 10/15/20224,920,000 shares $66.96 million -8.9%N/A4.8 $13.61 9/30/20225,400,000 shares $80.57 million +42.5%N/A5.2 $14.92 9/15/20223,790,000 shares $62.27 million +17.7%N/A3.4 $16.43 8/31/20223,220,000 shares $53.10 million -30.6%N/A1 $16.49World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. COGT Short Interest - Frequently Asked Questions What is Cogent Biosciences' current short interest? Short interest is the volume of Cogent Biosciences shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 10,840,000 shares of COGT short. Learn More on Cogent Biosciences' current short interest. What is a good short interest ratio for Cogent Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. COGT shares currently have a short interest ratio of 5.0. Learn More on Cogent Biosciences's short interest ratio. Is Cogent Biosciences' short interest increasing or decreasing? Cogent Biosciences saw a increase in short interest in March. As of March 31st, there was short interest totaling 10,840,000 shares, an increase of 12.6% from the previous total of 9,630,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cogent Biosciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Cogent Biosciences: Y-mAbs Therapeutics, Inc. (6.77%), Silence Therapeutics plc (0.54%), Evolus, Inc. (9.79%), Disc Medicine, Inc. (7.71%), Bicycle Therapeutics plc (8.46%), Pharming Group (0.00%), Savara Inc (5.57%), Aerovate Therapeutics, Inc. (5.78%), Praxis Precision Medicines, Inc. (2.66%), Dianthus Therapeutics, Inc. (6.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Cogent Biosciences stock? Short selling COGT is an investing strategy that aims to generate trading profit from Cogent Biosciences as its price is falling. COGT shares are trading down $0.42 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cogent Biosciences? A short squeeze for Cogent Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of COGT, which in turn drives the price of the stock up even further. How often is Cogent Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including COGT, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: YMAB Short Squeeze SLN Short Squeeze EOLS Short Squeeze IRON Short Squeeze BCYC Short Squeeze PHAR Short Squeeze SVRA Short Squeeze AVTE Short Squeeze PRAX Short Squeeze DNTH Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:COGT) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe World's First "$20 Trillion Drug?"Behind the MarketsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research